|Year : 2022 | Volume
| Issue : 2 | Page : 625
Patient with severe macular telangiectasia type I
In Hwan Hong1, In Hwan Cho2
1 Department of Ophthalmology, Dongtan Sacred Heart Hospital, Hallym University Medical Center, Hwaseong, Korea
2 Department of Ophthalmology, College of Medicine, Soonchunhyang University, Cheonan, Korea
|Date of Web Publication||13-Apr-2022|
In Hwan Cho
23-20 Bongmeong-dong Dongnam-gu, Cheonan 330-930
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Hong IH, Cho IH. Patient with severe macular telangiectasia type I. Indian J Ophthalmol Case Rep 2022;2:625
Ophthalmic images: A 40-year-old woman presented with progressive visual loss in her right eye. The fundus examination revealed thick circinate hard exudate around the macular area with multiple aneurysmal dilatations at the superotemporal to the fovea [Figure 1]a. The early phase of fluorescein angiography (FA) revealed multiple aneurysmal dilatations [Figure 1]b, while the late phase of FA showed dye leakage at the macular region [Figure 1]c. Large cystic space between the inner and outer retina with multiple intraretinal edemas corresponding to the aneurysms were observed in the horizontal scan of the optical coherence tomography [Figure 1]d. She was diagnosed with macular telangiectasia type 1 and treated with an intravitreal bevacizumab injection combined with focal laser photocoagulation. After treatment, the cystic space and intraretinal edema in the right eye were significantly decreased [Figure 1]e.
|Figure 1: Ultra-wide field fundus photograph shows severe macular edema with thick exudate in the patient with macular telangiectasia type I (a). Multiple aneurysmal dilatations at the superotemporal to the fovea are observed at the early phase of the fluorescein angiography (FA) (b). The late phase of the FA shows leakage of dye at the entire macular region (c). The horizontal optical coherence tomography scan shows a large cystic space with multiple intraretinal edemas (d). After treatment, the cystic space and intraretinal edema are significantly decreased (e)|
Click here to view
If macular edema in patients with macular telangiectasia type I is not properly managed, it can proceed to severe macular edema. The intravitreal bevacizumab injection combined with focal laser photocoagulation can be a useful treatment option for such patients.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1G1A1098872). This work was partially supported by the Soonchunhyang University Research Fund.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Chryssafis C, Neubauer AS, Papadopoulos E, Januschowski K, Boden KT, Szurman P. Intensified intravitreal bevacizumab treatment regime for type 1 and 2 idiopathic macular telangiectasia. Int J Ophthalmol 2016;9:1076-8.
Ciarnella A, Verrilli S, Fenicia V, Mannino C, Cutini A, Perdicchi A, et al
. Intravitreal ranibizumab and laser photocoagulation in the management of idiopathic juxtafoveolar retinal telangiectasia type 1: A case report. Case Rep Ophthalmol 2012;3:298-303.